Acuity Brands, Inc. (NYSE:AYI – Get Free Report) has been given an average rating of “Moderate Buy” by the six ratings firms that are currently covering the firm, MarketBeat reports. Three investment ...

MeiraGTx is advancing its investigational gene therapy toward expedited approval in the UK after 11 children who were born ...

His vision of technology as an enabler helped elevate and enhance relationships, which are at the heart of our business,' ...

StockNews.com upgraded shares of Acuity Brands (NYSE:AYI – Free Report) from a buy rating to a strong-buy rating in a ...

The following contains mild spoilers about "Zero Day." Conspiracy thrillers can feel like a dime a dozen in this age of ...

When my dad was young, he took off his own braces with pliers in the garage after his parents ran out of money to take him to ...

The following is a summary of “Impact of Dry Age-Related Macular Degeneration on Daily Activities and Quality of Life: ...

The New Hampshire Department of Environmental Services (NHDES) has scheduled a public hearing for March 6 pertaining to a ...

Acuity Brands, Inc. provides lighting, lighting controls, building management system, location-aware applications in the United States and internationally. The company operates in two segments ...

Eleven children who were legally blind at birth all gained visual acuity after receiving MeiraGTx's investigational gene ...